Performance analysis of Alterity Therapeutics (ATHE)
Annual Return
Over the past 3 years, ATHE has had an average annual return of +18.78%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, ATHE has had an average annual return of -18.81%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, ATHE has had an average annual return of -19.72%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Sep 5, 2002, ATHE has had an average annual return of -18.66%, underperforming the benchmark SPY, which returned +11.36% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +60% | -8.16% | +32.43% | -27.45% | -51.89% | -46.46% | +72.17% | -39.15% | -58.91% | +91.67% | -62.56% | -55.82% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -76.61% | +218.64% | +49.65% | +17.63% | -5.31% | -30.52% | -52.51% | +31.60% | +94.79% | -61.56% | -17.99% | -36.53% |
| 2002 | |||||||||||
| -30.97% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.44% | +8.51% | +0% | +31.37% | -8.96% | +29.51% | -8.86% | +60% | |||||
| 2025 | +44.90% | -21.13% | -8.93% | +0% | +29.41% | -9.09% | +25% | -2.67% | -24.66% | +12.73% | -14.52% | -15.09% | -8.16% |
| 2024 | -16.22% | -9.68% | +10.71% | +0% | -9.68% | -3.57% | -11.11% | -8.33% | -13.64% | -10.53% | +23.53% | +133.33% | +32.43% |
| 2023 | +13.73% | -18.97% | -12.77% | +0% | +4.88% | -4.65% | +4.88% | -6.98% | -7.50% | -8.11% | -20.59% | +37.04% | -27.45% |
| 2022 | +31.13% | -10.07% | -2.40% | -10.66% | -9.17% | -9.09% | -1.11% | -6.74% | -21.69% | -10.77% | -8.62% | -3.77% | -51.89% |
| 2021 | +22.73% | -2.88% | -10.17% | +0.94% | -7.48% | -3.03% | -1.04% | +5.79% | -6.97% | -3.74% | -20.56% | -25.87% | -46.46% |
| 2020 | +1.74% | -24.79% | +0% | +17.05% | -16.50% | +104.65% | +22.16% | +61.40% | -14.12% | -38.59% | +22.40% | -11.61% | +72.17% |
| 2019 | +24.87% | +0.42% | +16.88% | -8.30% | -24.02% | +0% | -22.80% | +10.74% | +1.82% | +1.79% | -20.47% | -15.44% | -39.15% |
| 2018 | -16.74% | +2.87% | -20.30% | -9.24% | +7.02% | -8.52% | +6.81% | +3.02% | -3.58% | -7.43% | -10.22% | -23.17% | -58.91% |
| 2017 | +54.17% | -12.70% | +43.03% | +1.52% | -33.90% | +9.03% | +22.19% | -4.60% | +4.82% | +9.20% | +6.87% | -4.56% | +91.67% |
Drawdown analysis of Alterity Therapeutics (ATHE)
The maximum drawdown for the ATHE was -99.87%, occurring on Nov 20, 2024. This drawdown has not yet recovered.
The current ATHE drawdown is -99.36%.
Since Sep 5, 2002 ATHE has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.87% | Sep 17, 2002 | 5583 | Nov 20, 2024 | Ongoing | Ongoing | Ongoing |
| -2.17% | Sep 6, 2002 | 3 | Sep 11, 2002 | 1 | Sep 12, 2002 | 4 |